MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 09-10-2025
Anixa Biosciences Operating Cash Flow 2011-2026 | ANIX
Annual Operating Cash Flow Anixa Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.34 M | -6.21 M | -6.49 M | -4.94 M | -6.18 M | -4.74 M | -4.27 M | -3.8 M | -3.38 M | 1.36 M | -2.38 M | -3.19 M | -3.14 M | -716 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.36 M | -7.34 M | -3.96 M |
Quarterly Operating Cash Flow Anixa Biosciences
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -2.31 M | - | - | - | -1.99 M | -4.9 M | - | - | -1.17 M | -3.89 M | -2.41 M | - | -1.91 M | -4.76 M | -3.47 M | - | -1.33 M | -3.4 M | -2.76 M | - | -1.34 M | -3.25 M | -2.08 M | - | -730 K | -3.06 M | -1.81 M | - | -532 K | -2.7 M | -1.88 M | - | 4.65 M | 2.17 M | 2.87 M | - | -1.17 M | -2.02 M | -1.68 M | - | -890 K | -2.64 M | -1.8 M | - | -657 K | -2.18 M | -1.55 M | - | -610 K | -3.51 K | -1.34 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.65 M | -4.9 M | -1.63 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 22.11 | - | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 22.36 | 17.07 % | $ 241 M |  China |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.6 | - | $ 2.03 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 40.61 | 1.35 % | $ 1.13 B | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 6.03 | - | $ 177 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 12.13 | -10.01 % | $ 344 M | Israel |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 28.01 | 7.77 % | $ 847 M | USA |
 |
Danaher Corporation
DHR
|
6.69 B | $ 235.57 | - | $ 172 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
DexCom
DXCM
|
748 M | $ 70.1 | - | $ 27.1 B | USA |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 101.63 | - | $ 18.8 B | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 18.9 | - | $ 1.02 B | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 109.17 | 3.95 % | $ 4.31 B | USA |
 |
Guardant Health
GH
|
-240 M | $ 109.93 | - | $ 13.5 B | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 244.29 | 1.58 % | $ 44.3 B | USA |
 |
Illumina
ILMN
|
837 M | $ 150.14 | - | $ 23.9 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 216.77 | - | $ 11.1 B | USA |
 |
Mettler-Toledo International
MTD
|
968 M | $ 1 470.87 | - | $ 31.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-8.7 M | $ 6.63 | - | $ 601 M | USA |
 |
National Research Corporation
NRC
|
38.1 M | $ 18.9 | -2.07 % | $ 464 M | USA |
 |
Natera
NTRA
|
-432 M | $ 254.4 | - | $ 25 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 178.14 | - | $ 19.8 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 5.96 | -1.16 % | $ 773 M | USA |
 |
OPKO Health
OPK
|
-183 M | $ 1.36 | - | $ 944 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 253.73 | - | $ 21.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 202.92 | - | $ 16.7 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 714.55 | - | $ 58.9 B | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 69.37 | -0.44 % | $ 4.8 B | USA |
 |
Agilent Technologies
A
|
1.48 B | $ 147.81 | 0.14 % | $ 44.9 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.78 | 5.41 % | $ 6.39 M | USA |
 |
Bioventus
BVS
|
15.3 M | $ 7.61 | -0.52 % | $ 477 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |